Finally, to account for a potential molecular subtype shift after ANXA2 inhibition, HuTuP174 primary GBM cells (isotype- or ANXA2 antibody-treated) were assigned to their specific molecular subtype according to the Verhaak classifier [29]. Here, ANXA2 is linked to glioblastoma.